Cytek Biosciences, Inc. (CTKB) › Shareholders' EquityCytek Biosciences, Inc. (CTKB) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: $41.70M2020: -$16.03M2021: $405.38M2022: $425.55M2023: $393.06M2024: $395.74M2025: $341.74M$341.74M2019Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$341.74M-13.6%2024$395.74M+0.7%2023$393.06M-7.6%2022$425.55M+5.0%2021$405.38M+2629.2%2020-$16.03M-138.4%2019$41.70M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share